Cerebrospinal Fluid Biomarkers for Detection of Alzheimer Disease in Patients with Mild...
Jun 1, 2018 - There is insufficient evidence to support the routine use of cerebrospinal fluid (CSF) biomarkers for the detection of progressive dementias in patients with mild cognitive impairment (MCI). These tests carry the risk of overdiagnosis of dementia and, therefore, overtreatment.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2018/0601/p714.html
Structural MRI for the Early Diagnosis of Alzheimer Disease in Patients with MCI - ...
Mar 1, 2021 - There is insufficient evidence to recommend structural brain magnetic resonance imaging to diagnose Alzheimer disease in patients with mild cognitive impairment.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2021/0301/p273.html
navigate_before 1 navigate_next